In this issue of Cardiology Clinics, guest editors Drs. Silvi Shah and Janani Rangaswami bring their considerable expertise to the topic of Cardio-Kidney-Metabolic Disorder. Top experts discuss key topics such as definition, staging, risk assessment, and therapeutic considerations; sex difference in CVD with kidney disease; obesity and CKM health:: ethnicity-based risk and clinical considerations; SGLT2i across the spectrum of CKM health; and more.
Cardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic Considerations Nonatherosclerotic Cardiovascular Disease in Chronic Kidney Disease Sex Differences in Cardiovascular Diseases and Vascular Function in Chronic Kidney Disease Obesity and Cardiovascular-Kidney-Metabolic Health: Ethnicity-Based Risk and Clinical Considerations Sodium Glucose Cotransporter 2 Inhibitors Across the Spectrum of Cardiovascular Kidney Metabolic Syndrome Role of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/ Glucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) Conditions Atherosclerotic Cardiovascular Disease in Cardiovascular-Kidney-Metabolic Syndrome Kidney Transplant and Cardiovascular-Kidney-Metabolic Health Long-Term Cardio-Renal-Metabolic Complications Following Pre-eclampsia A Plant-Based Diet for Cardiovascular Risk Reduction in Kidney Disease with a Focus on Cardiovascular-Kidney-Metabolic Syndrome Cardio-Kidney Metabolic Health in Pediatrics and Primordial Prevention History and Evolution of Hypertension Goals in Patients with Chronic Kidney Disease
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.
Dostawa
Płatność
Zwroty
